Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study.

Bengtsson K, Klingberg E, Deminger A, Wallberg H, Jacobsson LTH, Bergfeldt L, Forsblad-d'Elia H.

RMD Open. 2019 Nov 13;5(2):e001053. doi: 10.1136/rmdopen-2019-001053. eCollection 2019.

2.

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin.

Klingberg E, Magnusson MK, Strid H, Deminger A, Ståhl A, Sundin J, Simrén M, Carlsten H, Öhman L, Forsblad-d'Elia H.

Arthritis Res Ther. 2019 Nov 27;21(1):248. doi: 10.1186/s13075-019-2018-4.

3.

Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.

Mofors J, Björk A, Smedby KE, Kvarnström M, Forsblad-d'Elia H, Magnusson-Bucher S, Eriksson P, Mandl T, Baecklund E, Nordmark G, Wahren-Herlenius M.

Ann Rheum Dis. 2019 Nov 6. pii: annrheumdis-2019-216287. doi: 10.1136/annrheumdis-2019-216287. [Epub ahead of print] No abstract available.

PMID:
31694814
4.

Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.

Mofors J, Holmqvist M, Westermark L, Björk A, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Theander E, Mandl T, Wahren-Herlenius M, Nordmark G.

J Intern Med. 2019 Oct;286(4):458-468. doi: 10.1111/joim.12941. Epub 2019 Jun 17.

5.

Infections increase the risk of developing Sjögren's syndrome.

Mofors J, Arkema EV, Björk A, Westermark L, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Mandl T, Nordmark G, Wahren-Herlenius M.

J Intern Med. 2019 Jun;285(6):670-680. doi: 10.1111/joim.12888. Epub 2019 Apr 17.

PMID:
30892751
6.

Comparison of agreement between internet-based registration of patient-reported outcomes and clinic-based paper forms within the Swedish Rheumatology Quality Register.

Hofstedt O, Di Giuseppe D, Alenius GM, Stattin N, Forsblad-D'Elia H, Ljung L.

Scand J Rheumatol. 2019 Jul;48(4):326-330. doi: 10.1080/03009742.2018.1551964. Epub 2019 Feb 13.

PMID:
30758242
7.

Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study.

Klingberg E, Bilberg A, Björkman S, Hedberg M, Jacobsson L, Forsblad-d'Elia H, Carlsten H, Eliasson B, Larsson I.

Arthritis Res Ther. 2019 Jan 11;21(1):17. doi: 10.1186/s13075-019-1810-5.

8.

Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex.

Law L, Beckman Rehnman J, Deminger A, Klingberg E, Jacobsson LTH, Forsblad-d'Elia H.

Arthritis Res Ther. 2018 Dec 27;20(1):284. doi: 10.1186/s13075-018-1784-8.

9.

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.

Torres L, Klingberg E, Nurkkala M, Carlsten H, Forsblad-d'Elia H.

Osteoporos Int. 2019 Feb;30(2):441-449. doi: 10.1007/s00198-018-4721-4. Epub 2018 Oct 10.

10.

A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis.

Deminger A, Klingberg E, Geijer M, Göthlin J, Hedberg M, Rehnberg E, Carlsten H, Jacobsson LT, Forsblad-d'Elia H.

Arthritis Res Ther. 2018 Aug 3;20(1):162. doi: 10.1186/s13075-018-1665-1.

11.

Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women.

Engdahl C, Bondt A, Harre U, Raufer J, Pfeifle R, Camponeschi A, Wuhrer M, Seeling M, Mårtensson IL, Nimmerjahn F, Krönke G, Scherer HU, Forsblad-d'Elia H, Schett G.

Arthritis Res Ther. 2018 May 2;20(1):84. doi: 10.1186/s13075-018-1586-z.

12.

Uptake of rheumatology biosimilars in the absence of forced switching.

Di Giuseppe D, Frisell T, Ernestam S, Forsblad-D'Elia H, Lindqvist E, Lindström U, Sjöwall C, Askling J; ARTIS group.

Expert Opin Biol Ther. 2018 May;18(5):499-504. doi: 10.1080/14712598.2018.1458089. Epub 2018 Apr 10.

13.

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden.

Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH.

Ann Rheum Dis. 2018 Apr;77(4):541-548. doi: 10.1136/annrheumdis-2017-212189. Epub 2017 Dec 19.

PMID:
29259045
14.

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.

Frisell T, Baecklund E, Bengtsson K, Di Giuseppe D, Forsblad-d'Elia H, Askling J; ARTIS Study group.

Ann Rheum Dis. 2018 May;77(5):650-657. doi: 10.1136/annrheumdis-2017-212395. Epub 2017 Dec 13.

15.

Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.

Deminger A, Klingberg E, Lorentzon M, Geijer M, Göthlin J, Hedberg M, Rehnberg E, Carlsten H, Jacobsson LT, Forsblad-d'Elia H.

Arthritis Res Ther. 2017 Dec 8;19(1):273. doi: 10.1186/s13075-017-1480-0.

16.

Patterns of comorbidity and disease characteristics among patients with ankylosing spondylitis-a cross-sectional study.

Ljung L, Sundström B, Smeds J, Ketonen M, Forsblad-d'Elia H.

Clin Rheumatol. 2018 Mar;37(3):647-653. doi: 10.1007/s10067-017-3894-0. Epub 2017 Nov 8.

17.

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, Hammenfors D, Jonsson MV, Skarstein K, Brun JG; DISSECT consortium, Rönnblom L, Forsblad-d'Elia H, Magnusson Bucher S, Baecklund E, Theander E, Omdal R, Jonsson R, Nordmark G, Wahren-Herlenius M.

Biol Sex Differ. 2017 Aug 8;8(1):25. doi: 10.1186/s13293-017-0146-6.

18.

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.

Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH.

Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z.

19.

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.

Lie E, Lindström U, Zverkova-Sandström T, Olsen IC, Forsblad-d'Elia H, Askling J, Kapetanovic MC, Kristensen LE, Jacobsson LTH.

Ann Rheum Dis. 2017 Sep;76(9):1515-1521. doi: 10.1136/annrheumdis-2016-210931. Epub 2017 Mar 2.

PMID:
28254789
20.

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.

Klingberg E, Strid H, Ståhl A, Deminger A, Carlsten H, Öhman L, Forsblad-d'Elia H.

Arthritis Res Ther. 2017 Feb 2;19(1):21. doi: 10.1186/s13075-017-1223-2.

21.

Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.

Bengtsson K, Jacobsson LT, Rydberg B, Kvist G, Torstenson T, Dehlin M, Hilme E, Lindhé A, Wallerstedt SM, Forsblad-d'Elia H.

BMC Musculoskelet Disord. 2016 Dec 12;17(1):499.

22.

Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study.

Lindström U, Exarchou S, Lie E, Dehlin M, Forsblad-d'Elia H, Askling J, Jacobsson L.

Arthritis Res Ther. 2016 Oct 22;18(1):240.

23.

Explanatory factors and predictors of fatigue in persons with rheumatoid arthritis: A longitudinal study.

Feldthusen C, Grimby-Ekman A, Forsblad-d'Elia H, Jacobsson L, Mannerkorpi K.

J Rehabil Med. 2016 Apr 28;48(5):469-76. doi: 10.2340/16501977-2090.

24.

Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study.

Feldthusen C, Grimby-Ekman A, Forsblad-d'Elia H, Jacobsson L, Mannerkorpi K.

BMC Musculoskelet Disord. 2016 Feb 4;17:59. doi: 10.1186/s12891-016-0911-4.

25.

The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study.

Klingberg E, Oleröd G, Hammarsten O, Forsblad-d'Elia H.

Osteoporos Int. 2016 Jun;27(6):2027-33. doi: 10.1007/s00198-016-3489-7. Epub 2016 Jan 25.

PMID:
26809190
26.

Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers.

Lindström U, Forsblad-d'Elia H, Askling J, Kristensen LE, Lie E, Exarchou S, Jacobsson L.

Arthritis Res Ther. 2016 Jan 19;18:16. doi: 10.1186/s13075-016-0917-1.

27.

Effects of Person-Centered Physical Therapy on Fatigue-Related Variables in Persons With Rheumatoid Arthritis: A Randomized Controlled Trial.

Feldthusen C, Dean E, Forsblad-d'Elia H, Mannerkorpi K.

Arch Phys Med Rehabil. 2016 Jan;97(1):26-36. doi: 10.1016/j.apmr.2015.09.022. Epub 2015 Oct 16.

PMID:
26482574
28.

Mortality in ankylosing spondylitis: results from a nationwide population-based study.

Exarchou S, Lie E, Lindström U, Askling J, Forsblad-d'Elia H, Turesson C, Kristensen LE, Jacobsson LT.

Ann Rheum Dis. 2016 Aug;75(8):1466-72. doi: 10.1136/annrheumdis-2015-207688. Epub 2015 Sep 2.

PMID:
26338036
29.

Aortic Regurgitation Is Common in Ankylosing Spondylitis: Time for Routine Echocardiography Evaluation?

Klingberg E, Sveälv BG, Täng MS, Bech-Hanssen O, Forsblad-d'Elia H, Bergfeldt L.

Am J Med. 2015 Nov;128(11):1244-1250.e1. doi: 10.1016/j.amjmed.2015.04.032. Epub 2015 Jun 4.

PMID:
26052024
30.

The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.

Exarchou S, Lindström U, Askling J, Eriksson JK, Forsblad-d'Elia H, Neovius M, Turesson C, Kristensen LE, Jacobsson LT.

Arthritis Res Ther. 2015 May 9;17:118. doi: 10.1186/s13075-015-0627-0.

31.

Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register.

Lindström U, Exarchou S, Sigurdardottir V, Sundström B, Askling J, Eriksson JK, Forsblad-d'Elia H, Turesson C, Kristensen LE, Jacobsson L.

Scand J Rheumatol. 2015;44(5):369-76. doi: 10.3109/03009742.2015.1010572. Epub 2015 Mar 23.

PMID:
25797539
32.

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.

Lie E, Kristensen LE, Forsblad-d'Elia H, Zverkova-Sandström T, Askling J, Jacobsson LT; ARTIS Study Group.

Ann Rheum Dis. 2015 Jun;74(6):970-8. doi: 10.1136/annrheumdis-2014-206616. Epub 2015 Feb 20.

PMID:
25710471
33.

Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.

Forsblad-d'Elia H, Bengtsson K, Kristensen LE, Jacobsson LT.

Rheumatology (Oxford). 2015 Jul;54(7):1186-93. doi: 10.1093/rheumatology/keu455. Epub 2014 Dec 13.

PMID:
25505001
34.

Prevalence of diastolic dysfunction in patients with ankylosing spondylitis: a cross-sectional study.

Sveälv BG, Täng MS, Klingberg E, Forsblad-d'Elia H, Bergfeldt L.

Scand J Rheumatol. 2015;44(2):111-7. doi: 10.3109/03009742.2014.953201. Epub 2014 Nov 25.

PMID:
25421143
35.

Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.

Klingberg E, Nurkkala M, Carlsten H, Forsblad-d'Elia H.

J Rheumatol. 2014 Jul;41(7):1349-56. doi: 10.3899/jrheum.131199.

PMID:
24931960
36.

Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes.

Klingberg E, Lorentzon M, Göthlin J, Mellström D, Geijer M, Ohlsson C, Atkinson EJ, Khosla S, Carlsten H, Forsblad-d'Elia H.

Arthritis Res Ther. 2013;15(6):R179.

37.

Role of androgen and estrogen receptors for the action of dehydroepiandrosterone (DHEA).

Engdahl C, Lagerquist MK, Stubelius A, Andersson A, Studer E, Ohlsson C, Westberg L, Carlsten H, Forsblad-d'Elia H.

Endocrinology. 2014 Mar;155(3):889-96. doi: 10.1210/en.2013-1561. Epub 2014 Jan 1.

PMID:
24424045
38.

Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study.

Mörck B, Pullerits R, Geijer M, Bremell T, Forsblad-d'Elia H.

Mediators Inflamm. 2013;2013:289845. doi: 10.1155/2013/289845. Epub 2013 Sep 5.

39.

Soluble E-cadherin in systemic lupus erythematosus.

Jin T, Almehed K, Zhu Y, Carlsten H, Forsblad-d'Elia H.

J Rheumatol. 2013 Oct;40(10):1677-82. doi: 10.3899/jrheum.130518. Epub 2013 Sep 1.

PMID:
23996289
40.

Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.

Nordmark G, Wang C, Vasaitis L, Eriksson P, Theander E, Kvarnström M, Forsblad-d'Elia H, Jazebi H, Sjöwall C, Reksten TR, Brun JG, Jonsson MV, Johnsen SJ, Wahren-Herlenius M, Omdal R, Jonsson R, Bowman S, Ng WF, Eloranta ML, Syvänen AC; UK Primary Sjögren’s Syndrome Registry.

Scand J Immunol. 2013 Nov;78(5):447-54. doi: 10.1111/sji.12101.

41.

Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study.

Forsblad-d'Elia H, Wallberg H, Klingberg E, Carlsten H, Bergfeldt L.

BMC Musculoskelet Disord. 2013 Aug 12;14:237. doi: 10.1186/1471-2474-14-237.

42.

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.

Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, Forsblad-d'Elia H, Omdal R, Wahren-Herlenius M, Jonsson R, Rönnblom L, Nititham J, Taylor KE, Lessard CJ, Sivils KL, Gottenberg JE, Criswell LA, Miceli-Richard C, Zitvogel L, Mariette X.

Sci Transl Med. 2013 Jul 24;5(195):195ra96. doi: 10.1126/scitranslmed.3005727.

43.

Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis.

Kastbom A, Klingberg E, Verma D, Carlsten H, Forsblad-d'Elia H, Wesamaa J, Cedergren J, Eriksson P, Söderkvist P.

Scand J Rheumatol. 2013;42(6):465-8. doi: 10.3109/03009742.2013.779020. Epub 2013 Apr 2.

PMID:
23547871
44.

Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years.

Bertilsson L, Andersson-Gäre B, Fasth A, Petersson IF, Forsblad-D'elia H.

J Rheumatol. 2013 May;40(5):715-24. doi: 10.3899/jrheum.120602. Epub 2013 Feb 15.

PMID:
23418376
45.

Perception, consequences, communication, and strategies for handling fatigue in persons with rheumatoid arthritis of working age--a focus group study.

Feldthusen C, Björk M, Forsblad-d'Elia H, Mannerkorpi K; University of Gothenburg Centre for Person-Centred Care (GPCC).

Clin Rheumatol. 2013 May;32(5):557-66. doi: 10.1007/s10067-012-2133-y. Epub 2013 Jan 5.

PMID:
23292480
46.

Exosomal secretion of death bullets: a new way of apoptotic escape?

Trokovic N, Pöllänen R, Porola P, Stegaev V, Hetzel U, Tivesten Å, Engdahl C, Carlsten H, Forsblad-d'Elia H, Fagman JB, Lagerquist M, Konttinen YT.

Am J Physiol Endocrinol Metab. 2012 Oct 15;303(8):E1015-24. doi: 10.1152/ajpendo.00139.2012. Epub 2012 Aug 21.

47.

Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton.

Klingberg E, Geijer M, Göthlin J, Mellström D, Lorentzon M, Hilme E, Hedberg M, Carlsten H, Forsblad-D'Elia H.

J Rheumatol. 2012 Oct;39(10):1987-95. doi: 10.3899/jrheum.120316. Epub 2012 Aug 15.

PMID:
22896024
48.

A 5-year prospective population-based study of juvenile chronic arthritis: onset, disease process, and outcome.

Bertilsson L, Andersson-Gäre B, Fasth A, Forsblad-d'Elia H.

Scand J Rheumatol. 2012 Oct;41(5):379-82. doi: 10.3109/03009742.2012.677472. Epub 2012 May 29.

PMID:
22639832
49.

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment.

Klingberg E, Lorentzon M, Mellström D, Geijer M, Göthlin J, Hilme E, Hedberg M, Carlsten H, Forsblad-d'Elia H.

Arthritis Res Ther. 2012 May 8;14(3):R108. doi: 10.1186/ar3833.

50.

Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.

Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d'Elia H.

Scand J Gastroenterol. 2012 Apr;47(4):435-44. doi: 10.3109/00365521.2011.648953. Epub 2012 Jan 10.

PMID:
22229862

Supplemental Content

Loading ...
Support Center